Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation

[1] Chien KL(2010)Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese Int J Cardiol 139 173-180

[2] Su TC(2016)2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation J Formos Med Assoc 115 893-952

[3] Hsu HC(2018)Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in asians with nonvalvular atrial fibrillation J Am Heart Assoc 7 e008150-2104

[4] Chang WT(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 2071-31

[5] Chen PC(2018)Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors Cardiol Res Pract 2018 7408129-233

[6] Chen MF(2017)The theory and practice of surrogate decision-making Hastings Cent Rep 47 29-2469

[7] Chiang CE(2020)Shared decision-making: the patient on the forefront of care coordination Eur Heart J Qual Care Clin Outcomes 6 231-76

[8] Wu TJ(2016)Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study Stroke 47 2462-2962

[9] Ueng KC(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 e1-962

[10] Chao TF(2016)2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Eur Heart J 37 2893-1785

[1] Chien KL(2010)Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese Int J Cardiol 139 173-180

[2] Su TC(2016)2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation J Formos Med Assoc 115 893-952

[3] Hsu HC(2018)Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in asians with nonvalvular atrial fibrillation J Am Heart Assoc 7 e008150-2104

[4] Chang WT(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 2071-31

[5] Chen PC(2018)Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors Cardiol Res Pract 2018 7408129-233

[6] Chen MF(2017)The theory and practice of surrogate decision-making Hastings Cent Rep 47 29-2469

[7] Chiang CE(2020)Shared decision-making: the patient on the forefront of care coordination Eur Heart J Qual Care Clin Outcomes 6 231-76

[8] Wu TJ(2016)Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study Stroke 47 2462-2962

[9] Ueng KC(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 e1-962

[10] Chao TF(2016)2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Eur Heart J 37 2893-1785